Literature DB >> 25711429

Inflammatory profiling of early experimental necrotizing pancreatitis.

Lutz Schneider1, Bahar Jabrailova2, Oliver Strobel2, Thilo Hackert2, Jens Werner3.   

Abstract

AIMS: Inflammatory mediators play a pivotal role in severe necrotizing pancreatitis (SNP). Therapeutic approaches aim at the early inflammatory liberation of cytokines to avoid systemic complications. The present study evaluates the kinetics of inflammatory mediator release in SNP. MAIN
METHODS: Experimental SNP was induced in male Wistar rats using the GDOC model. The animals were allocated into seven groups (n = 6/group). In group 1, sample harvesting was performed after sham operation while in groups 2-7 this was performed 1 h, 2 h, 4 h, 6 h, 9 h, and 12 h after initiation of SNP, respectively. Inflammatory mediator release,morphologic injury, and tissue MPO concentrations were evaluated between 1 and 12 h after induction. KEY
FINDINGS: Pancreatic injury showed a continuous increase over the observation period (p b 0.05, respectively). MPO levels in the pancreas and lungs increased until 12 h after induction (p b 0.05, respectively). Antiinflammatory IL-10 showed an early peak and the pro-inflammatory mediators TNFα and IL-1β peaked after 6 and 9 h, respectively (p b 0.05, respectively). HMGB1 levels constantly increased over time (p b 0.05, respectively). SIGNIFICANCE: The present study shows the release of relevant pro- and anti-inflammatory mediators in SNP for the first time in one single experimental setup. Inflammatory mediators peak within the first few hours after SNP induction. Consequently, the effect of therapeutic approaches on early changes in cytokine release should be evaluated later than 2 h after initiation.

Entities:  

Keywords:  Acute pancreatitis; Cytokines; Experimental; Myeloperoxidase; Necrotizing pancreatitis; Severe pancreatitis; Systemic complications

Mesh:

Substances:

Year:  2015        PMID: 25711429     DOI: 10.1016/j.lfs.2015.01.029

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Ginsenoside Rg3 ameliorates acute pancreatitis by activating the NRF2/HO‑1‑mediated ferroptosis pathway.

Authors:  Yuqiang Shan; Jiaotao Li; Akao Zhu; Wencheng Kong; Rongchao Ying; Weiming Zhu
Journal:  Int J Mol Med       Date:  2022-05-18       Impact factor: 5.314

2.  miR-340-5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1.

Authors:  Yazhou Gao; Liming Wang; Zequn Niu; Hui Feng; Jie Liu; Jiangli Sun; Yanxia Gao; Longfei Pan
Journal:  Exp Ther Med       Date:  2021-12-14       Impact factor: 2.447

Review 3.  HMGB1 and Histones Play a Significant Role in Inducing Systemic Inflammation and Multiple Organ Dysfunctions in Severe Acute Pancreatitis.

Authors:  Runkuan Yang; Jyrki Tenhunen; Tor Inge Tonnessen
Journal:  Int J Inflam       Date:  2017-02-21

Review 4.  Effect of Endotoxemia in Suckling Rats on Pancreatic Integrity and Exocrine Function in Adults: A Review Report.

Authors:  Jolanta Jaworek; Barbara Tudek; Paweł Kowalczyk; Michalina Kot; Joanna Szklarczyk; Anna Leja-Szpak; Piotr Pierzchalski; Joanna Bonior; Artur Dembiński; Piotr Ceranowicz; Zygmunt Warzecha; Katarzyna Nawrot-Porąbka; Krzysztof Gil
Journal:  Gastroenterol Res Pract       Date:  2018-01-14       Impact factor: 2.260

5.  Decreased MIZ1 Expression in Severe Experimental Acute Pancreatitis: A Rat Study.

Authors:  Ping Chen; Weiyi Wang; Yongping Zhang; Yaozong Yuan; Yunlin Wu
Journal:  Dig Dis Sci       Date:  2015-11-18       Impact factor: 3.487

6.  Association of HMGB1 Gene Polymorphisms with Risk of Colorectal Cancer in a Chinese Population.

Authors:  Jian-Xin Wang; Hua-Long Yu; Shao-Sheng Bei; Zhen-Hua Cui; Zhi-Wen Li; Zhen-Ji Liu; Yan-Feng Lv
Journal:  Med Sci Monit       Date:  2016-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.